Replies to post #13255 on $heff's $tation of $tocks & $olid DD

[Investor100]

Upcoming FDA drug approvals.

Sheff, borrowed from another board forum which might be of interest added information.

Investor 100

Symbol Company
Drug FDA Deadline
SLXP Salix Pharmaceuticals
Sanvar 5/19/2009
HEB Hemispherx BioPharma Ampligen
SOON
ACUS Acusphere
Imagify 5/31/2009
ABIO ARCA biopharma
Gencaro 5/31/2009
DSCO Discovery Laboratories
Surfaxin 6/2/2009
BDSI BioDelivery Sciences International Onsolis 6/15/2009
SVNT Savient Pharmaceuticals KRYSTEXXA
6/16/2009
SPPI Spectrum Pharm Zevalin
7/2/2009
DDSS Labopharm
trazodone 7/18/2009
TSPT Transcept Pharmaceuticals Intermezzo
7/30/2009
ADLS Advanced Life Science cethromycin
7/31/2009
CTIC Cell Therapeutics
pixzntrone 12/1/2009
VION Vion Pharmaceuticals Onrigin
12/12/2009
AMRN Amarin Corporation AMR101 Phase
III
OGXI OncoGenx Pharmaceuticals OGX-011 Phase
III
ANPI Angiotech Pharmaceuticals TAXUS
Researching

[$heff]

Investor100...w/TELK that is some pretty good data. The trend was toward survival in the treatment arm with the TELIK drug even though the study was not statistically powered for overall survival. Safety data was good as well. The PFS was almost 2 months greater in the treatment arm vs control arm. Not sure it will cause the stock to set fire but it allows the study to move into a potential pivotal Phase III trial.

Best, Sheff